Lizzi C. Lee speaks with Gary Rieschel about what's behind China's biotech boom, potential risks, and long-term global ...
American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...
Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...
What if China decided to sever American access to the drug ingredients your sick kid depends on? But America’s losing ...
In a sign it is willing to go further in responding to President Trump’s tariffs, Beijing blocked more American companies ...
A recent CNN report cast a spotlight on Akeso, a Chinese biotech company whose immunotherapy ivonescimab drug, now in ...
China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war ...
They provide leverage that Trump should use to strike a deal with China to more comprehensively regulate its pharmaceutical ...
BeiGene's Tevimbra wins FDA approval for first-line metastatic ESCC treatment, showing significant survival benefits in PD-L1 ...
China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...
China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback